Freeline Therapeutics Holdings plc ADR buy Wedbush
Start price
04.10.23
/
50%
€3.21
Target price
04.10.24
€7.61
Performance (%)
0.00%
End price
05.10.24
-
Summary
This prediction is currently being closed. The BUY prediction by Wedbush is currently unchanged from the start price. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Freeline Therapeutics Holdings plc ADR | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% |
Comments by Wedbush for this prediction
In the thread Freeline Therapeutics Holdings plc ADR diskutieren
Freeline Therapeutics Holdings plc (NASDAQ: FRLN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock, up previously from $5.00.
Ratings data for FRLN provided by MarketBeat
In the thread Trading Freeline Therapeutics Holdings plc ADR
Die von Wedbush gewählte maximale Laufzeit wurde überschritten